COVID-19 international border surveillance at Toronto's Pearson Airport: a cohort study

BMJ Open. 2021 Jul 1;11(7):e050714. doi: 10.1136/bmjopen-2021-050714.

Abstract

Objectives: The primary objective was to estimate the positivity rate of air travellers coming to Toronto, Canada in September and October 2020, on arrival and on day 7 and day 14. The secondary objectives were to estimate the degree of risk based on country of origin and to assess knowledge and attitudes towards COVID-19 control measures and subjective well-being during the quarantine period.

Design: Prospective cohort of arriving international travellers.

Setting: Toronto Pearson Airport Terminal 1, Toronto, Canada.

Participants: Participants of this study were passengers arriving on international flights. Inclusion criteria were those aged 18 or older who had a final destination within 100 km of the airport, spoke English or French, and provided consent. Excluded were those taking a connecting flight, had no internet access, exhibited symptoms of COVID-19 on arrival or were exempted from quarantine.

Main outcome measures: Positive for SARS-CoV-2 virus on reverse transcription PCR with self-administered oral-nasal swab and general well-being using the WHO-5 Well-being Index.

Results: Of 16 361 passengers enrolled, 248 (1.5%, 95% CI 1.3% to 1.7%) tested positive. Of these, 167 (67%) were identified on arrival, 67 (27%) on day 7, and 14 (6%) on day 14. The positivity rate increased from 1% in September to 2% in October. Average well-being score declined from 19.8 (out of a maximum of 25) to 15.5 between arrival and day 7 (p<0.001).

Conclusions: A single arrival test will pick up two-thirds of individuals who will become positive by day 14, with most of the rest detected on the second test on day 7. These results support strategies identified through mathematical models that a reduced quarantine combined with testing can be as effective as a 14-day quarantine.

Keywords: COVID-19; diagnostic microbiology; epidemiology; public health.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Airports
  • COVID-19*
  • Canada
  • Cohort Studies
  • Humans
  • Prospective Studies
  • SARS-CoV-2